Nacoti M, Cazzaniga S, Colombo G, Corbella D, Fazzi F, Fochi O, Gattoni C, Zambelli M, Colledan M, Bonanomi E
Pediatric Intensive Care Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Bergamo Anesthesia and Intensive Care Community (BAIC), Bergamo, Italy.
Pediatr Transplant. 2017 Dec;21(8). doi: 10.1111/petr.13020. Epub 2017 Jul 5.
Intraoperative transfusions seem associated with patient death and graft failure after PLTx. A retrospective analysis of recipients' and donors' characteristics and transplantation data in a cohort of patients undergoing PLTx from 2002 to 2009 at the Bergamo General Hospital was performed. A two-stage hierarchical Cox proportional hazard regression with forward stepwise selection was used to identify the main risk factors for major complications. In addition, propensity score analysis was used to adjust risk estimates for possible selection biases in the use of blood products. Over the 12-year period, 232 pediatric cirrhotic patients underwent PLTx. One-year patient and graft survival rates were 92.3% and 83.7%, respectively. The Kaplan-Meier shows that the main decrease in both graft and patient survival occurs during the first months post-transplantation. At the same time, it appears that most of the complications occur during the first month post-transplantation. One-month and 1-year patient complication-free survival rates were 24.8% and 12.1%, respectively. Our study shows that intraoperative red blood cells and platelet transfusions are independent risk factors for developing one or more major complications in the first year after PLTx. Decreasing major complications will improve the health status and overall long-term patient survival after pediatric PLTx.
肝移植术中输血似乎与患者死亡及肝移植术后移植物功能衰竭有关。对2002年至2009年在贝加莫综合医院接受肝移植的一组患者的受者和供者特征及移植数据进行了回顾性分析。采用两阶段分层Cox比例风险回归及向前逐步选择法来确定主要并发症的主要危险因素。此外,倾向评分分析用于调整血液制品使用中可能的选择偏倚的风险估计。在这12年期间,232例小儿肝硬化患者接受了肝移植。患者1年生存率和移植物生存率分别为92.3%和83.7%。Kaplan-Meier分析显示,移植物和患者生存率的主要下降发生在移植后的头几个月。同时,似乎大多数并发症发生在移植后的第一个月。患者1个月和1年无并发症生存率分别为24.8%和12.1%。我们的研究表明,肝移植术中输注红细胞和血小板是肝移植术后第一年发生一种或多种主要并发症的独立危险因素。减少主要并发症将改善小儿肝移植术后患者的健康状况和总体长期生存率。